![Cetuximab / Pfizer / Amines / ImClone Systems / Head and neck cancer / Colorectal cancer / Irinotecan / FOLFIRI / KRAS / Medicine / Eli Lilly and Company / Bristol-Myers Squibb Cetuximab / Pfizer / Amines / ImClone Systems / Head and neck cancer / Colorectal cancer / Irinotecan / FOLFIRI / KRAS / Medicine / Eli Lilly and Company / Bristol-Myers Squibb](https://www.pdfsearch.io/img/e0cdb93c43939726200c1a2763f1809b.jpg) Date: 2014-01-17 12:57:49Cetuximab Pfizer Amines ImClone Systems Head and neck cancer Colorectal cancer Irinotecan FOLFIRI KRAS Medicine Eli Lilly and Company Bristol-Myers Squibb | | IMPORTANT: PLEASE READ tolerate other irinotecan-based chemotherapy. PART III: CONSUMER INFORMATION In patients who cannot tolerate irinotecan. In patients who have failed on both irinotecan- and PrAdd to Reading ListSource URL: www.bmscanada.caDownload Document from Source Website File Size: 150,93 KBShare Document on Facebook
|